J.P. Morgan Private Wealth Advisors LLC - CRINETICS PHARMACEUTICALS IN ownership

CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 139 filers reported holding CRINETICS PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 19.18 and the average weighting 0.3%.

Quarter-by-quarter ownership
J.P. Morgan Private Wealth Advisors LLC ownership history of CRINETICS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$348,759
+9.9%
19,354
-2.1%
0.00%
+100.0%
Q1 2023$317,362
-9.8%
19,761
+2.8%
0.00%0.0%
Q4 2022$351,65319,2160.00%
Other shareholders
CRINETICS PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
RA Capital Management 1,875,209$28,203,0001.68%
Opaleye Management Inc. 207,000$3,113,0001.13%
Perceptive Advisors 2,587,953$38,922,0001.05%
New Leaf Venture Partners, L.L.C. 141,000$2,121,0000.64%
Orbimed Advisors 2,039,282$30,671,0000.58%
Eventide Asset Management 947,000$14,243,0000.47%
Novo Holdings A/S 135,009$2,031,0000.35%
Baker Brothers Advisors 175,000$2,632,0000.02%
Polar Capital LLP 90,382$1,359,0000.01%
Point72 Asset Management, L.P. 132,000$1,985,0000.01%
View complete list of CRINETICS PHARMACEUTICALS IN shareholders